Updated: 2/17/2011
Absalus develops monoclonal antibodies.
Absalus was acquired by EvoGenix in 2005.
Employment
Email:
Fax:
Mail:
General Info:
Keywords:
BiotechCareerCenter.com - a Deep13 site © 2004 Shawn C. Baker. All rights reserved.